文献速递牙周病

半乳糖凝集素3对脂多糖诱导人牙龈成纤维细胞生物学行为的影响

[Effect of galectin-3 on lipopolysaccharide-induced proliferation, migration, apoptosis, reactive oxygen species and inflammatory cytokine production in human gingival fibroblasts].
PubMed 文献 · Zhonghua Kou Qiang Yi Xue Za Zhi · 2025-01-01

该研究从6例牙周健康者牙龈组织提取人牙龈成纤维细胞,用慢病毒敲低或过表达Gal-3,观察LPS诱导下细胞增殖、迁移、凋亡、活性氧及IL-6、IL-8的变化。结果显示敲低Gal-3抑制增殖、迁移和炎症因子产生并促进凋亡,过表达则相反,机制可能与JAK-STAT通路相关。

要点

  • 敲低Gal-3可抑制LPS诱导的牙龈成纤维细胞增殖与迁移。
  • 敲低Gal-3促进凋亡并减少活性氧、IL-6和IL-8产生。
  • 过表达Gal-3呈现相反效应,提示其参与牙周炎调控。

核心结论

  • 敲低Gal-3抑制LPS诱导的GF增殖、迁移及活性氧、IL-6、IL-8产生并促进凋亡,过表达则相反。
  • 该过程可能与JAK-STAT信号转导途径密切相关。

研究设计与样本

  • 2022年12月至2023年12月于山东大学齐鲁医学院口腔医学院·口腔医院牙周病科收集6例牙周健康者牙龈组织。
  • 采用酶消化法提取并培养GF,用慢病毒实现Gal-3敲低和过表达。
  • 设置shNC+LPS、shGal-3+LPS、oeNC+LPS和oeGal-3+LPS四组进行体外实验。
  • 采用EdU、Ki67染色、划痕迁移、TUNEL、免疫荧光和RT-qPCR检测相关指标,并用RNA-seq分析差异基因与通路富集。

主要发现

  • shGal-3 MOI 40及oeGal-3 MOI 70可使80%以上GF成功转染。
  • shGal-3组Gal-3基因和蛋白表达(0.26±0.01、0.26±0.03)显著低于shNC组(1.00±0.03、1.00±0.09)(P<0.001)。
  • oeGal-3组Gal-3基因和蛋白表达(4.26±0.05、3.94±0.34)显著高于oeNC组(1.00±0.00、1.00±0.24)(P<0.001)。
  • shGal-3+LPS组GF增殖比例[(16.99±1.79)%、(13.48±0.95)%]显著低于shNC+LPS组[(33.86±3.84)%、(35.63±1.62)%](P<0.05)。
  • oeGal-3+LPS组GF增殖比例[(45.36±1.56)%、(45.83±1.50)%]显著高于oeNC+LPS组[(34.47±1.02)%、(33.66±3.14)%](P<0.05)。

关键数值与推荐

  • shGal-3+LPS组GF迁移率[(25.07±0.01)%]显著低于shNC+LPS组[(57.84±0.00)%](P<0.001)。
  • oeGal-3+LPS组GF迁移率[(74.70±0.03)%]显著高于oeNC+LPS组[(53.36±0.01)%](P<0.001)。
  • LPS刺激下shGal-3显著促进GF凋亡(P<0.05),oeGal-3显著抑制GF凋亡(P<0.001)。
  • 敲低Gal-3显著降低GF中活性氧产生及IL-6、IL-8基因水平表达(均P<0.001)。
  • 过表达Gal-3显著增加GF中活性氧产生及IL-6、IL-8基因水平表达(均P<0.001)。

临床怎么用

  • Gal-3可能作为牙周炎炎症调控的潜在分子靶点。
  • 体外结果提示调节Gal-3表达可影响牙龈成纤维细胞在LPS刺激下的炎症与修复反应。
  • 仍需进一步体内研究验证其临床转化价值。

局限性

  • 仅基于6例牙周健康者来源的GF体外实验,样本量有限。
  • 机制结论主要来自RNA-seq通路富集,未进行通路功能验证。
  • 未涉及牙周炎患者组织或体内模型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the effects of galectin-3 (Gal-3) expression on lipopolysaccharide (LPS)-induced proliferation, migration, apoptosis, reactive oxygen species (ROS) and inflammatory cytokine production in human gingival fibroblasts (GF) as well as its mechanism, thus laying the foundation for an in-depth discussion of the regulatory role of Gal-3 in periodontitis and its mechanisms. Methods: Gingival tissues from 6 periodontally healthy subjects undergoing crown lengthening were collected at the Department of Periodontology, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University from December 2022 to December 2023. GFs were extracted and cultured by collagenase digestion. Lentivirals with multiplicity of infection (MOI) of 15, 20, 30, 40, 50, 60, 70, 80 were used to achieve knockdown and overexpression of Gal-3 gene in GFs, whose efficiencies of Gal-3 gene were detected by using immunofluorescence, real-time fluorescence quantitative PCR (RT-qPCR) and Western blotting. Negative control of knockdown (shNC)+LPS group, Gal-3 knockdown (shGal-3)+LPS group, negative control of overexpression (oeNC)+LPS group, and Gal-3 overexpression (oeGal-3)+LPS group were established, respectively. 5-Ethynyl-2'-deoxyuridine (EdU), Ki67 staining, scratch migration assay, terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) technology, immunofluorescence assay and RT-qPCR were used to investigate the effects of Gal-3 on LPS-induced proliferation, migration, apoptosis, ROS, interleukin (IL)-6, IL-8 expression. The effects of Gal-3 knockdown on the expression of differential genes and the enrichment of signaling pathways in LPS-induced GFs were investigated by RNA sequencing (RNA-seq). Results: More than 80% of GFs were successfully transfected by shGal-3 MOI 40 and oeGal-3 MOI 70. Immunofluorescence results showed that the morphologies of GFs were normal after lentiviral transfection, and green fluorescence could be distributed in the cytoplasm, nucleus, and cell membrane. The results of RT-qPCR and Western blotting assay showed that the expressions of Gal-3 at the gene and protein levels in shGal-3 group (0.26±0.01, 0.26±0.03, respectively) were significantly lower than those in the shNC group (1.00±0.03, 1.00±0.09, respectively) (P<0.001); the expressions of Gal-3 at the gene and protein levels in the oeGal-3 group (4.26±0.05, 3.94±0.34) were significantly higher than those in the oeNC group (1.00±0.00, 1.00±0.24, respectively) (P<0.001). EdU, Ki67 experiments showed that the percentage of GFs proliferation was significantly lower in the shGal-3+LPS group [(16.99±1.79)%, (13.48±0.95)%, respectively] than in the shNC+LPS group [(33.86±3.84)%, (35.63±1.62)%, respectively] (P<0.05), and the proliferation ratio of GFs was significantly increased in the oeGal-3+LPS group [(45.36±1.56)%, (45.83±1.50)%, respectively] compared to the oeNC+LPS group [(34.47±1.02)%, (33.66±3.14)%, respectively] (P<0.05). The results of scratch migration assay showed that the migration ratio of GFs in shGal-3+LPS group significantly decreased compared to the shNC+LPS group [(25.07±0.01)% vs (57.84±0.00)%] (P<0.001), whereas the oeGal-3+LPS group significantly facilitated the migration ratio of GFs compared to the oeNC+LPS group [(74.70±0.03)% vs (53.36±0.01)%] (P<0.001). The results of TUNEL experiments showed that LPS stimulation with shGal-3 promoted apoptosis of GFs (P<0.05), whereas oeGal-3 inhibited apoptosis of GFs (P<0.001). Immunofluorescence experiments and RT-qPCR results showed that knockdown of Gal-3 significantly reduced ROS production, IL-6 and IL-8 expression levels at the gene level in GFs (P<0.001), whereas overexpression of Gal-3 significantly increased the production of ROS and the expression of IL-6 and IL-8 at the gene level in GFs (P<0.001). RNA-seq results showed that differential genes caused by Gal-3 knockdown under LPS conditions were significantly enriched in biological processes such as cellular response to type Ⅰinterferon in the Gene Ontology database and in the Kyoto Encyclopedia of Genes and Genomes database for NOD-like receptor, RIG-I like receptor and other signaling pathways. Conclusions: Gal-3 knockdown inhibited LPS-induced proliferation, migration, ROS, IL-6 and IL-8 production, and promoted apoptosis of GFs, while overexpression had the opposite effect. This process might be closely linked to the Janus kinase-signal transducer and activator of transcription pathway. 目的: 探究半乳糖凝集素3(Gal-3)表达对脂多糖(LPS)诱导的人牙龈成纤维细胞(GF)增殖、迁移、凋亡以及活性氧和炎症因子产生的影响并探索其机制,为深入探讨Gal-3在牙周炎中的调控作用及其机制奠定基础。 方法: 2022年12月至2023年12月于山东大学齐鲁医学院口腔医学院·口腔医院牙周病科收集6例需行牙冠延长术牙周健康者的牙龈组织,应用酶消化法提取并培养GF。设置感染复数(MOI)为15、20、30、40、50、60、70、80的慢病毒用以实现GF中Gal-3基因的敲低和过表达,利用免疫荧光实验、实时荧光定量PCR(RT-qPCR)及蛋白质印迹法检测Gal-3基因的敲低及过表达效率;分别设置Gal-3敲低阴性对照(shNC)+LPS组、Gal-3敲低(shGal-3)+LPS组、Gal-3过表达阴性对照(oeNC)+LPS组和Gal-3过表达(oeGal-3)+LPS组,通过5-乙炔基-2′-脱氧尿苷(EdU)、Ki67染色,划痕迁移实验,原位末端转移酶标记(TUNEL)技术,免疫荧光实验和RT-qPCR分别探究Gal-3对LPS诱导的GF增殖、迁移、凋亡以及活性氧和白细胞介素(IL)-6、IL-8基因表达的影响;通过RNA测序(RNA-seq)技术探究敲低Gal-3对LPS诱导的GF中差异基因表达及信号通路富集的影响。 结果: shGal-3 MOI 40及oeGal-3 MOI 70的慢病毒即可使80%以上的GF成功实现转染,免疫荧光结果显示慢病毒转染后GF形态正常,绿色荧光可分布于细胞质、细胞核及细胞膜。RT-qPCR和蛋白质印迹法结果显示,shGal-3组Gal-3在基因和蛋白水平上的表达(0.26±0.01、0.26±0.03)均显著低于shNC组(1.00±0.03、1.00±0.09)(P<0.001);oeGal-3组Gal-3在基因和蛋白水平的表达(4.26±0.05、3.94±0.34)均显著高于oeNC组(1.00±0.00、1.00±0.24)(P<0.001)。EdU、Ki67实验结果显示,shGal-3+LPS组GF的增殖比例[(16.99±1.79)%、(13.48±0.95)%]均显著低于shNC+LPS组[(33.86±3.84)%、(35.63±1.62)%](P<0.05),oeGal-3+LPS组GF的增殖比例[(45.36±1.56)%、(45.83±1.50)%]均显著高于oeNC+LPS组[(34.47±1.02)%、(33.66±3.14)%](P<0.05)。划痕迁移实验结果显示,shGal-3+LPS组GF迁移率[(25.07±0.01)%]显著低于shNC+LPS组[(57.84±0.00)%](P<0.001),oeGal-3+LPS组GF迁移率[(74.70±0.03)%]显著高于oeNC+LPS组[(53.36±0.01)%](P<0.001)。TUNEL结果表明,LPS刺激下,shGal-3显著促进了GF的凋亡(P<0.05),而oeGal-3显著抑制了GF的凋亡(P<0.001)。免疫荧光实验及RT-qPCR结果显示,敲低Gal-3显著降低了GF中活性氧的产生及IL-6和IL-8在基因水平的表达(均P<0.001),而过表达Gal-3显著增加了GF中活性氧的产生及IL-6和IL-8在基因水平的表达(均P<0.001)。RNA-seq结果显示,LPS条件下Gal-3敲低引起的差异基因显著富集到基因本体数据库中细胞对Ⅰ型干扰素反应等生物过程,并富集于京都基因与基因组数据库中NOD样受体及RIG-I样受体等信号通路中。 结论: 下调Gal-3的表达能抑制LPS诱导的GF增殖、迁移以及活性氧、IL-6、IL-8的产生,促进GF凋亡;过表达作用则与之相反,此过程可能与JAK-STAT信号转导途径密切相关。.

来源:Zhonghua Kou Qiang Yi Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Song WJ, Kang WY, Ge SH, et al. [Effect of galectin-3 on lipopolysaccharide-induced proliferation, migration, apoptosis, reactive oxygen species and inflammatory cytokine production in human gingival fibroblasts]. Zhonghua Kou Qiang Yi Xue Za Zhi. 2025. PMID: 40734401. doi:10.3760/cma.j.cn112144-20241115-00431

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。